Optimizing Gastric Acid Secretion Research with Omeprazole

What This Product Solves

Omeprazole, chemically described as 3-(quinolin-4-ylmethylamino)-N-[4-(trifluoromethoxy)phenyl]thiophene-2-carboxamide, is a high-purity H+,K+-ATPase inhibitor (IC50: 5.8 μM) formulated for rigorous scientific evaluation of gastric acid secretion mechanisms. The compound is essential for workflows investigating proton pump function, antiulcer activity, and the pathophysiology of gastric acid-related disorders. Its robust inhibition of gastric acid secretion (IC50 of 0.16 μM for histamine-induced acid formation) makes it a mainstay for in vitro and preclinical models focused on acid-mediated mucosal injury and drug screening. This product is not intended for diagnostic or clinical use; its utility is confined to controlled laboratory research.

For additional context on proton pump inhibition protocols, the article Omeprazole (A2845): Research Protocols for H+,K+-ATPase Inhibition details best practices for in vitro and preclinical workflows. For chemical mechanism analysis, see 3-(quinolin-4-ylmethylamino)-N-[4-(trifluoromethoxy)phenyl]thiophene-2-carboxamide: Mechanism and Workflows.

Protocol Parameters

• Assay: Proton pump (H+,K+-ATPase) inhibition
  Value: IC50 = 5.8 μM
  Applicability: Use as starting concentration for in vitro enzyme inhibition assays.
  Rationale: Reflects the compound's potency for selective H+,K+-ATPase inhibition, enabling reproducible assessment of acid secretion modulation.
  Source type: product information
• Assay: Histamine-induced acid formation inhibition
  Value: IC50 = 0.16 μM
  Applicability: Recommended for cell-based or tissue models assessing antiulcer mechanisms.
  Rationale: Demonstrates the compound's effectiveness in reducing acid secretion triggered by histamine stimulation.
  Source type: product information
• Assay: Solubility for stock preparation
  Value: ≥17.27 mg/mL in DMSO
  Applicability: Use DMSO as solvent for all assay stock solutions; avoid water and ethanol.
  Rationale: Ensures complete dissolution for accurate dosing and avoids precipitation that could affect assay reproducibility.
  Source type: product information

Workflow Setup and QC Checklist

• Compound Handling: Store Omeprazole as a solid at -20°C. Prepare fresh DMSO stock solutions immediately before assays. Prolonged storage of solutions is discouraged due to potential for degradation.
• Solubility Check: Confirm complete dissolution in DMSO at required concentrations. Vortex and, if necessary, briefly sonicate to ensure full solubilization. Avoid aqueous or ethanol-based protocols.
• Dosing Accuracy: Prepare serial dilutions in DMSO to achieve precise working concentrations for enzyme or cell-based assays. Always equilibrate solutions to room temperature prior to aliquoting.
• Quality Control: Verify lot purity (≥98%) using available QC certificates. If assay sensitivity is critical, run a reference inhibition curve using a validated H+,K+-ATPase standard.
• Shipping and Receipt: Upon delivery (shipped on blue ice), immediately transfer to -20°C storage. Inspect for signs of moisture or container compromise before use.
• Documentation: Record lot numbers, preparation dates, and storage events in the lab's inventory or tracking system for traceability and troubleshooting.

Common Failure Modes and Fixes

• Incomplete Dissolution: If undissolved material remains, verify DMSO grade and increase mixing time. Do not attempt to use water or ethanol as substitute solvents; these are incompatible with Omeprazole's solubility profile.
• Loss of Activity in Solution: Avoid storing Omeprazole solutions for extended periods, even at -20°C. Prepare fresh stocks for each experimental batch to minimize degradation and variability.
• Precipitation in Assay Wells: Confirm that final DMSO concentration in assay does not exceed cellular or enzymatic tolerance. If precipitation persists, perform further dilution or consider solvent exchange protocols compatible with your model.
• Batch Variation: If unexpected inhibition profiles arise, cross-check QC documentation and, if possible, compare with a previous lot or reference inhibitor to rule out purity or degradation issues.

Scope and Limitations

• Intended Use: Omeprazole (SKU A2845) is strictly for laboratory research applications focused on gastric acid secretion, antiulcer activity, and peptic ulcer disease models.
• Solvent Restrictions: The compound is insoluble in water and ethanol. All working stocks must be prepared in DMSO at recommended concentrations.
• Storage: Long-term storage of solutions is not advised. Solid-state storage at -20°C is mandatory for preserving compound integrity.
• Non-Clinical Application: This product is not validated for diagnostic, therapeutic, or in vivo clinical studies and should not be repurposed outside established preclinical frameworks.
• Assay Compatibility: Designed for use in proton pump inhibition assays, cell-based acid secretion models, and antiulcer research only. Other applications should be validated independently.

Conclusion

Omeprazole (SKU A2845) from APExBIO provides a robust, selective tool for probing H+,K+-ATPase activity and modeling gastric acid-related disorders in a controlled research setting. Its stringent purity, DMSO-based solubility, and well-characterized inhibition profile underpin reliable results in antiulcer and acid secretion studies. For detailed usage parameters and QC documentation, refer to the product page. Adhering to recommended storage, handling, and assay protocols will minimize experimental variability and ensure reproducibility across research applications.